Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: Methods and systems are provided that include: obtaining sensor data pertaining to a roadway in which a host vehicle and an emergency vehicle are both travelling; generating, using map data pertaining to the roadway, a grid of a plurality of potential cells along the roadway for the host vehicle to pull over to yield right of way to the emergency vehicle; prioritizing, via a processor of the host vehicle, the plurality of potential cells based on a plurality of different criteria as to conditions of the host vehicle and the roadway; selecting, via the processor, one of the plurality of potential cells as an optimal pull over location for the host vehicle along the roadway, based on the prioritizing of the plurality of cells; and taking a vehicle action for the host vehicle, in accordance with instructions provided by the processor, with respect to the optimal pull over location.

Abstract: According to examples, an apparatus may include a processor and a computer readable medium on which is stored machine readable instructions that may cause the processor to receive a request for a webpage from a web browser. The processor may send webpage code of the webpage to the web browser and the webpage may load a secure webpage for a sensitive data field that is separate from the webpage. A secure server may provide the secure webpage, which may correspond to an identifier that points to the secure server. By receiving the sensitive data into the sensitive data field of the secure webpage, the sensitive data may be protected from a script loaded in the webpage. In addition, the processor may receive the sensitive data from the secure server.

Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: According to examples, an apparatus may include a processor and a computer readable medium on which is stored machine readable instructions that may cause the processor to receive a request for a webpage from a web browser. The processor may send webpage code of the webpage to the web browser and the webpage may load a secure webpage for a sensitive data field that is separate from the webpage. A secure server may provide the secure webpage, which may correspond to an identifier that points to the secure server. By receiving the sensitive data into the sensitive data field of the secure webpage, the sensitive data may be protected from a script loaded in the webpage. In addition, the processor may receive the sensitive data from the secure server.

Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract: The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Abstract: Embodiments of the invention use incomplete metadata, automated heuristics, and user input to construct a data model implemented by a set of commands used in a scripting environment. A combination of a static analysis and a runtime analysis of the scripting environment may be used to determine the data model. Commands that enumerate resources are identified. Return types for the commands are discovered either from a definition of the command or by running the command with default parameters. Properties for the return types are identified and key fields are identified for indexing. Relationships between the return types are identified, and additional commands associated with the return types are identified. The return type properties are analyzed to identify updatable return types. A data model of the scripting environment is created from the collected information.

Abstract: Network connection information is requested by a wireless wide area network device via the internet. Such information may include configuration information, data roaming partner information, and/or cost information regarding roaming partner connection and/or a subscriber plan related to the wireless wide area network. To retrieve the information, the wireless device sends a request to a redirection server, which in turn provides an internet address for a provisioning server, or instructs a provisioning server to provide the network configuration information to the wireless device. A user and/or the wireless device may use the network connection information when deciding whether and/or how to connect to the network. A network provider may use methods disclosed herein to efficiently update wireless devices that subscribe to the network. The network provider may provide selected network connection information based on information regarding the wireless device, such as the user identification.

Abstract: Network connection information is requested by a wireless wide area network device via the internet. Such information may include configuration information, data roaming partner information, and/or cost information regarding roaming partner connection and/or a subscriber plan related to the wireless wide area network. To retrieve the information, the wireless device sends a request to a redirection server, which in turn provides an internet address for a provisioning server, or instructs a provisioning server to provide the network configuration information to the wireless device. A user and/or the wireless device may use the network connection information when deciding whether and/or how to connect to the network. A network provider may use methods disclosed herein to efficiently update wireless devices that subscribe to the network. The network provider may provide selected network connection information based on information regarding the wireless device, such as the user identification.

Abstract: The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract: Embodiments of the invention use incomplete metadata, automated heuristics, and user input to construct a data model implemented by a set of commands used in a scripting environment. A combination of a static analysis and a runtime analysis of the scripting environment may be used to determine the data model. Commands that enumerate resources are identified. Return types for the commands are discovered either from a definition of the command or by running the command with default parameters. Properties for the return types are identified and key fields are identified for indexing. Relationships between the return types are identified, and additional commands associated with the return types are identified. The return type properties are analyzed to identify updatable return types. A data model of the scripting environment is created from the collected information.

Abstract: The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract: A novel mixed salt of S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine is disclosed. The novel mixed salt, S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride, may be produced to form crystals that may be arranged as generally orderly packed agglomerates, which are particularly useful in making pharmaceutical compositions. Such pharmaceutical compositions are also described, as well as methods to make crystalline S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride, and methods of treating conditions characterized by an overexpression on nitric oxide from the inducible isoform of nitric oxide synthase using the S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride.

Abstract: The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract: A novel mixed salt of S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine is disclosed. The novel mixed salt, S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride, may be produced to form crystals that may be arranged as generally orderly packed agglomerates, which are particularly useful in making pharmaceutical compositions. Such pharmaceutical compositions are also described, as well as methods to make crystalline S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride, and methods of treating conditions characterized by an overexpression on nitric oxide from the inducible isoform of nitric oxide synthase using the S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride.